Picture of Autolus Therapeutics logo

AUTL Autolus Therapeutics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousSmall CapSucker Stock

U.S. STOCKS ON THE MOVE-Kenvue, Tapestry, Ralph Lauren

* 
      Eikon search string for individual stock moves:  STXBZ 
    

        * 
      The Day Ahead newsletter: https://refini.tv/3LI4BU7
    

        * 
      The Morning News Call newsletter: https://refini.tv/3dKUyB8
    

  
U.S. stock index futures slipped on Thursday, following a strong finish on Wall
Street a day earlier, with investors sizing up big-ticket earnings reports and
looking forward to data that could offer clues on the economy's health.  .N 
    
    At 9:08 ET, Dow e-minis  1YMc1  were up 0.07% at 38,801. S&P 500 e-minis
 ESc1  were down 0.08% at 5,011, while Nasdaq 100 e-minis  NQc1  were down 0.11%
at 17,823.
 
 The top three NYSE percentage gainers premarket  .PRPG.NQ :
 ** Oscar Health  OSCR.K , up 25.4%
 ** CURO Group Holdings Corp  CURO.K , up 18.6%
 ** Leju Holdings  LEJU.K , up 15.7%
 
 The top three NYSE percentage losers premarket  .PRPL.NQ :
 ** Bakkt Holdings  BKKT.K , down 28.3%
 ** Envista Holdings  NVST.K , down 12.3%
 ** MariaDB  MRDB.K , down 11.5%
 
 The top three Nasdaq percentage gainers premarket  .PRPG.O :
 ** Syra Health  SYRA.O , up 552.6%
 ** Hitek Global  HKIT.O , up 448.2%
 ** CCSC Technology International Holdings  CCTG.O , up 133.6%
 
 The top Nasdaq percentage losers premarket  .PRPL.O :
 ** Tenax Therapeutics  TENX.O , down 64.7%
 
 
 ** Arm Holdings PLC  ARM.O : up 26.2% premarket
 BUZZ - Charges ahead after raising FY forecasts, Q3 results beat  urn:newsml:reuters.com:*:nL4N3ET2CH 

 ** PayPal Holdings Inc  PYPL.O : down 8.6% premarket
 BUZZ - Falls after flat profit growth forecast in FY24  urn:newsml:reuters.com:*:nL4N3ET2GO 
    
 ** New York Community Bancorp Inc  NYCB.N : down 0.9% premarket
 BUZZ - Stock back in red day after closing higher  urn:newsml:reuters.com:*:nL4N3ET2LA 
    
 ** Autolus Therapeutics PLC  AUTL.O : up 2.8% premarket
 BUZZ - Climbs on collaboration with BioNTech to develop CAR-T cell therapies
 urn:newsml:reuters.com:*:nL4N3ET2S1 
    
 ** Oscar Health Inc  OSCR.N : up 25.4% premarket
 BUZZ -  Jumps on upbeat revenue forecast for 2024  urn:newsml:reuters.com:*:nL4N3ET2YY 
    
 ** BorgWarner Inc  BWA.N : down 5.6% premarket
 BUZZ - Slips on downbeat FY forecast, Q4 results miss  urn:newsml:reuters.com:*:nL4N3ET329 
    
 ** Iris Energy Ltd  IREN.O : up 6.8% premarket
 BUZZ - Up as it commences GPU cloud service business  urn:newsml:reuters.com:*:nL4N3ET2YR 
    
 ** Under Armour Inc  UAA.N : up 5.2% premarket
 BUZZ - Surges after annual profit forecast raise on easing costs  urn:newsml:reuters.com:*:nL4N3ET33X 
    
 ** Fluence Energy Inc  FLNC.O : down 3.6% premarket
 BUZZ - Falls after Q1 revenue misses estimates  urn:newsml:reuters.com:*:nL4N3ET2KL 
    
 ** Kenvue Inc  KVUE.N : down 2.5% premarket
 BUZZ - Down as annual profit forecast falls below estimates  urn:newsml:reuters.com:*:nL4N3ET34U 
    
 ** Tapestry Inc  TPR.N : up 2.6% premarket
 BUZZ - Up after FY profit forecast raise, quarterly sales beat  urn:newsml:reuters.com:*:nL4N3ET3BL 
    
 ** Spirit Airlines Inc  SAVE.N : up 3.2% premarket
 BUZZ - Rises on narrower-than-expected Q4 loss  urn:newsml:reuters.com:*:nL4N3ET39Q 
    
 ** Ralph Lauren Corp  RL.N : up 6.0% premarket
 BUZZ - Jumps on Q3 sales beat, FY profit margin outlook raise  urn:newsml:reuters.com:*:nL4N3ET377 
    
 ** Dynatrace Inc  DT.N : down 10.6% premarket
 BUZZ - Drops as it cuts FY24 ARR growth forecast  urn:newsml:reuters.com:*:nL4N3ET3J4 
    
 ** Foghorn Therapeutics Inc  FHTX.O : up 11.9% premarket
 BUZZ - Up as Eli Lilly picks its cancer therapy for development  urn:newsml:reuters.com:*:nL4N3ET3KI 
    
 ** Baxter International Inc  BAX.N : down 1.1% premarket
 BUZZ - Falls after forecasting 2024 profit largely below estimates  urn:newsml:reuters.com:*:nL4N3ET3KR

 (Compiled by Rajarshi Roy and Arasu Kannagi Basil in Bengaluru)
 ((ArasuKannagi.Basil@thomsonreuters.com;))

Recent news on Autolus Therapeutics

See all news